Diagens Completes HK$790 Million Initial Public Offering on Hong Kong Stock Exchange

Laura Testa Asia & Pacific Legal Chronicle
Tagged:

O’Melveny has advised Hangzhou Diagens Biotechnology Co., Ltd. in its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. Hangzhou…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here